Phuturdex › Diseases › Human body weight
Drugs in development · updated 30 October 2026
Human body weight: drugs in development
As of 30 October 2026 there are 19 active clinical trials (recruiting or ongoing, phases I–III) on 13 drugs for human body weight. 8 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| Maridebart cafraglutide | III | 3 | NCT07866066 |
| Olatorepatide | III | 3 | NCT07896265 |
| PF-08653944 | III | 3 | NCT07595549 |
| Berobenatide | III | 2 | NCT07874633 |
| VK2735 | III | 2 | NCT07868939 |
| PF-08653945 | II | 1 | NCT07575932 |
| Retatrutide | II | 1 | NCT07467447 |
| MBX 4291 | I | 1 | NCT07142707 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| SemaglutideWegovy, Rybelsus | III | 2 | NCT07866066 |
| EmpagliflozinJardiance | II | 2 | NCT07336797 |
| TirzepatideZepbound, Mounjaro | II | 2 | NCT07046819 |
| MetforminRiomet Er®, Glumetza® | I | 1 | NCT06446531 |
| PioglitazoneActos, Pioglitazone Accord® | I | 1 | NCT06446531 |
Sorted by most advanced phase and number of active trials.
All 13 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Obesity 233 drugs
- Overweight 139 drugs
- Type 2 diabetes 171 drugs
- Weight loss 26 drugs
- Insulin resistance 41 drugs
- Obstructive sleep apnea 32 drugs
- Pediatric Obesity 11 drugs
- Cachexia 9 drugs
- Type-1 diabetes 80 drugs
- Neoplasm 671 drugs
- Prediabetes 18 drugs
- Diabetes 91 drugs
Broader categories
- Nutritional and metabolic diseases 5 drugs
- Overnutrition 5 drugs
- Nutrition disorder 10 drugs
- Metabolic disease 30 drugs
- Glucose metabolism disease 12 drugs
- Endocrine system disease 19 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D001835 “Body Weight”.